XML 99 R63.htm IDEA: XBRL DOCUMENT v3.24.1
Summary of Significant Accounting Policies - Additional Information - Graphite Bio, Inc. (Details)
12 Months Ended
Dec. 31, 2023
USD ($)
integer
Dec. 31, 2022
USD ($)
SummaryOfSignificantAccountingPoliciesTable [Line Items]    
Impairment losses $ 0 $ 0
Maximum    
SummaryOfSignificantAccountingPoliciesTable [Line Items]    
Property, plant, and equipment, useful life 5 years  
Minimum    
SummaryOfSignificantAccountingPoliciesTable [Line Items]    
Property, plant, and equipment, useful life 3 years  
Graphite Bio, Inc.    
SummaryOfSignificantAccountingPoliciesTable [Line Items]    
Number of reportable segments | integer 1  
Number of operating segments | integer 1  
Restricted cash $ 100,000 1,700,000
Restricted cash equivalents 1,602,000 0
Impairment losses $ 54,100,000 $ 0
Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration] Impairment of assets  
Research and development credits to offset payroll tax expenses $ 300,000  
Graphite Bio, Inc. | ESPP Shares Available for Future Grants    
SummaryOfSignificantAccountingPoliciesTable [Line Items]    
Share based compensation arrangement by share based payment award, exercise price percentage 15.00%  
Offering period term of contract 6 months  
Graphite Bio, Inc. | Maximum    
SummaryOfSignificantAccountingPoliciesTable [Line Items]    
Liquid investments maturity period 3 months